<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7202545\results\search\drug\results.xml">
  <result pre="have limitations. Previous studies showed that postulated geroprotectors, such as" exact="sirolimus" post="(rapamycin) and its close derivative rapalog everolimus (RAD001), decreased"/>
  <result pre="geroprotectors, such as sirolimus (rapamycin) and its close derivative rapalog" exact="everolimus" post="(RAD001), decreased infection rates in a small sample of"/>
  <result pre="undergone clinical evaluation for this purpose. Keywords: COVID-19 SARS-CoV-2 coronavirus" exact="sirolimus" post="rapalog INTRODUCTION Aging is a complex, multifactorial process [1]"/>
  <result pre="viral disease [31]. For influenza, the neuraminidase inhibitors oseltamivir and" exact="zanamivir" post="are occasionally given prophylactically to high-risk individuals in long-term"/>
  <result pre="cost and may be associated with side effects; for example," exact="zanamivir" post="can induce bronchospasms in patients with chronic respiratory disease"/>
  <result pre="efficacy, neurological side effects, and widespread resistance, adamantanes (M2 inhibitors," exact="amantadine" post="and rimantadine), are only active against influenza A [31]."/>
  <result pre="still limited by a lack of large clinical trials, are" exact="sirolimus" post="(rapamycin) and everolimus. These may be used as single"/>
  <result pre="also delays age-related diseases in humans [65â€&quot;68], and Blagosklonny proposed" exact="rapamycin" post="for the prevention of multiple age-related diseases in humans"/>
  <result pre="derivatives and mimetics of rapamycin, target critical factors in the" exact="rapamycin" post="(TOR) pathway. Everolimus (RAD001), another close structural derivative of"/>
  <result pre="rapamycin (TOR) pathway. Everolimus (RAD001), another close structural derivative of" exact="sirolimus" post="developed by Novartis, acts as an immunosuppressant; but like"/>
  <result pre="the cyclical secretion that occurs physiologically, which normally indirectly increases" exact="testosterone" post="levels, actually reduces hormone levels. Therefore, it might be"/>
  <result pre="Torin2, AZD8055, PP242, KU-006379 and GSK1059615, may act similarly to" exact="rapamycin" post="in low-doses and may have a geroprotective effect [77â€&quot;79]."/>
  <result pre="that patients with cytomegalovirus (CMV) disease who were treated with" exact="rapamycin" post="demonstrated better outcomes and were better able to control"/>
  <result pre="following transplantation [74, 80]. In 2009, two seminal studies of" exact="sirolimus" post="demonstrated the immunostimulatory effects of rapamycin on the CD8+"/>
  <result pre="two seminal studies of sirolimus demonstrated the immunostimulatory effects of" exact="rapamycin" post="on the CD8+ memory T cell response following pathogen"/>
  <result pre="[74, 80]. Later studies also showed that monkeys treated with" exact="sirolimus" post="exhibited increased recall responses and enhanced differentiation of memory"/>
  <result pre="role of rapalogs in the elderly using the Novartis rapalog" exact="everolimus" post="(RAD001), a close structural analog of sirolimus (rapamycin). Administration"/>
  <result pre="the Novartis rapalog everolimus (RAD001), a close structural analog of" exact="sirolimus" post="(rapamycin). Administration of everolimus ameliorated immunosenescence in healthy elderly"/>
  <result pre="(RAD001), a close structural analog of sirolimus (rapamycin). Administration of" exact="everolimus" post="ameliorated immunosenescence in healthy elderly volunteers and enhanced the"/>
  <result pre="which demonstrated that a low-dose combination of dactolisib (BEZ235) and" exact="everolimus" post="in an elderly population was safe and associated with"/>
  <result pre="(BEZ235), a PI3K inhibitor [84] and catalytic mTOR inhibitor, and" exact="everolimus" post="in an elderly population was safe and associated with"/>
  <result pre="endpoint and further trials were withdrawn [85]. In prior studies," exact="everolimus" post="(RAD001) was used as a standalone agent or in"/>
  <result pre="protection against SARS-CoV-2 (COVID-19) and other gerophilic and gerolavic infections." exact="Metformin" post="Metformin is a drug approved to treat type 2"/>
  <result pre="against SARS-CoV-2 (COVID-19) and other gerophilic and gerolavic infections. Metformin" exact="Metformin" post="is a drug approved to treat type 2 diabetes"/>
  <result pre="decreasing IGF-1 levels, inhibiting mTOR, and inhibiting mitochondrial complex 1." exact="Metformin" post="is currently in the first large-scale human clinical trial"/>
  <result pre="large-scale human clinical trial of aging, the Targeting Aging with" exact="Metformin" post="(TAME) study, which is investigating its effect on time"/>
  <result pre="outcome that includes cardiovascular events, cancer, dementia, and mortality [87]." exact="Metformin" post="would likely still be contraindicated in elderly patients with"/>
  <result pre="TAME study, and other clinical trials involving metformin. NAD boosters" exact="Nicotine" post="adenine dinucleotide (NAD) is a cofactor of multiple fundamental"/>
  <result pre="study, and other clinical trials involving metformin. NAD boosters Nicotine" exact="adenine" post="dinucleotide (NAD) is a cofactor of multiple fundamental enzymes."/>
  <result pre="human data have been reported with the tyrosine kinase inhibitor" exact="dasatinib" post="in combination with the plant flavonol quercetin in a"/>
  <result pre="nephrotoxicity although milder side effect profile reported in preliminary studies." exact="Metformin" post="mTOR inhibition.Mitochondrial complex 1 inhibition.Reduction of hepatic gluconeogenesis. Long-term"/>
  <result pre="it may be entirely plausible that the immunomodulatory properties of" exact="rapamycin" post="may go beyond prevention and may provide an effective"/>
  <result pre="that several geroprotective and senoremediative interventions, such as treatment with" exact="sirolimus" post="and rapalogs, can induce immunopotentiation, increase resistance to infection,"/>
  <result pre="of this article, another group utilizing computational approaches proposed using" exact="melatonin" post="and sirolimus (rapamycin) in combination to treat the COVID-19"/>
  <result pre="article, another group utilizing computational approaches proposed using melatonin and" exact="sirolimus" post="(rapamycin) in combination to treat the COVID-19 infection outside"/>
  <result pre="speculative aging reversal treatments, such as experimental geroprotective strategies using" exact="everolimus" post="(RAD001) and sirolimus (rapamycin). We summarize the current possible"/>
  <result pre="treatments, such as experimental geroprotective strategies using everolimus (RAD001) and" exact="sirolimus" post="(rapamycin). We summarize the current possible interventions and identify"/>
  <result pre="comments.BMJ. 2014; 348:g2545. 10.1136/bmj.g254524811411 40HeneghanCJ, OnakpoyaI, ThompsonM, SpencerEA, JonesM, JeffersonT." exact="Zanamivir" post="for influenza in adults and children: systematic review of"/>
  <result pre="CorteseF, ArtemovA, Karpinsky-SemperD, MoskalevA, SwickAG, ZhavoronkovA. Towards natural mimetics of" exact="metformin" post="and rapamycin.Aging (Albany NY). 2017; 9:2245â€&quot;68. 10.18632/aging.10131929165314 52AspinallR, LangPO."/>
  <result pre="10.1016/j.cub.2004.03.05915186745 58ScialÃ²F, SriramA, NaudÃ­A, AyalaV, JovÃ©M, PamplonaR, SanzA. Target of" exact="rapamycin" post="activation predicts lifespan in fruit flies.Cell Cycle. 2015; 14:2949â€&quot;58."/>
  <result pre="Glover-CutterK, LammingDW, MizunumaM, NarasimhanSD, Neumann-HaefelinE, SabatiniDM, BlackwellTK. TOR signaling and" exact="rapamycin" post="influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO.Cell Metab. 2012;"/>
  <result pre="ToshkovI, KuropatwinskiKK, ChernovaOB, PolinskyA, BlagosklonnyMV, GudkovAV, AntochMP. New nanoformulation of" exact="rapamycin" post="Rapatar extends lifespan in homozygous p53-/- mice by delaying"/>
  <result pre="RostaingL, KreisH, BurkeJT, BraultY, et al.. Sirolimus therapy after early" exact="cyclosporine" post="withdrawal reduces the risk for cancer in adult renal"/>
  <result pre="Immunol. 2018; 9:2953. 10.3389/fimmu.2018.0295330619313 74FerrerIR, ArakiK, FordML. Paradoxical aspects of" exact="rapamycin" post="immunobiology in transplantation.Am J Transplant. 2011; 11:654â€&quot;59. 10.1111/j.1600-6143.2011.03473.x21446969 75GarcÃ­a-SastreA,"/>
  <result pre="Garcia-EchevrriaC, YungWK. NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of" exact="rapamycin" post="inhibitor, elicits multifaceted antitumor activities in human gliomas.Mol Cancer"/>
  <result pre="Search of: Rad001, Certican, Rapamycin, Rapamune.https://clinicaltrials.gov/ct2/results?cond=&amp;amp;term=rad001&amp;amp;cntry=&amp;amp;state=&amp;amp;city=&amp;amp;dist=&amp;amp;rslt=With&amp;amp;phase=2 87BarzilaiN, CrandallJP, KritchevskySB, EspelandMA." exact="Metformin" post="as a Tool to Target Aging.Cell Metab. 2016; 23:1060â€&quot;65."/>
 </snippets>
</snippetsTree>
